REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Trading 03-10 09:58:58

87.900

+2.550

+2.99%

High88.650	Low85.650	Vol1.43M
Open86.300	D1 Closing85.350	Amplitude3.51%
Mkt Cap49.54B	Tradable Cap18.33B	Total Shares563.61M
T/O125.16M	T/O Rate0.69%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":87.9,"timestamp":1773107935851,"preClose":85.35,"halted":0,"volume":1430500,"delay":0,"changeRate":0.02987697715289996,"floatShares":208581239,"shares":563608243,"eps":1.4640074156354135,"marketStatus":"Trading","change":2.55,"latestTime":"03-10 09:58:58","open":86.3,"high":88.65,"low":85.65,"amount":125159744,"amplitude":0.035149,"askPrice":87.9,"askSize":1000,"bidPrice":87.8,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-2.0870617343825777,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1773115200000},"marketStatusCode":2,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":85.35,"openAndCloseTimeList":[[1773106200000,1773115200000],[1773118800000,1773129600000]],"volumeRatio":2.870299,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":112.85,"timestamp":1773107937000,"preClose":107.33,"halted":0,"volume":3559200,"delay":0,"premium":"-31.37"}},"requestUrl":"/m/hq/s/09995/wiki","defaultTab":"wiki","newsList":[{"id":"1188158271","title":"RemeGen Shares Surge Over 6% on Strong 2025 Profit Turnaround and Projected Cash Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1188158271","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188158271?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:24","pubTimestamp":1772763863,"startTime":"0","endTime":"0","summary":"RemeGEN (09995) rose more than 6%, with the stock up 6.44% to HK$81.75 at the time of writing, generating a turnover of HK$170 million. The company recently released its 2025 preliminary results,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","688331","BK4588","LU2148510915.USD","BK1161","LU2488822045.USD","VT","BK0239","BK1583","BK1574","LU1064131003.USD","BK4585","VXUS","LU2328871848.SGD","09995","LU1969619763.USD"],"gpt_icon":0},{"id":"1145091404","title":"RemeGen (09995) Announces Monthly Equity Movements and Public Float Status","url":"https://stock-news.laohu8.com/highlight/detail?id=1145091404","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145091404?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:13","pubTimestamp":1772615604,"startTime":"0","endTime":"0","summary":"RemeGen (09995) released a monthly update for the period ended 28 February 2026, reporting no changes in its overall share structure. The total authorized and registered share capital stood at 564.48...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"2616804404","title":"RemeGen Returns to Profit in 2025; Shares Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804404","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616804404?lang=en_us&edition=fundamental","pubTime":"2026-03-02 12:46","pubTimestamp":1772426798,"startTime":"0","endTime":"0","summary":"RemeGen  returned to profit in 2025, swinging year on year to a net profit attributable to owners of 708.5 million yuan, or 1.29 yuan per share, according to a Hong Kong filing disclosure on Saturday.The biopharmaceutical company's Hong Kong shares slumped less than 6%, while Shanghai shares fell less than 3% during Monday's midday trade.The attributable loss a year earlier was 1.47 billion yuan, or 2.73 yuan per share.Total operating revenue jumped 89% to 3.25 billion yuan from 1.72 billion yuan in the previous year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","LU1969619763.USD","BK0239","LU2148510915.USD","LU2328871848.SGD","BK1574","BK1161","LU1064131003.USD","LU1064130708.USD","09995","LU2488822045.USD","688331"],"gpt_icon":0},{"id":"1153539601","title":"REMEGEN Reports Annual Profit of 709 Million Yuan, Turning Around from Previous Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1153539601","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153539601?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:30","pubTimestamp":1772191820,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has announced its preliminary financial results for the 2025 fiscal year. The company achieved total operating revenue of RMB 3.251 billion, representing a year-on-year increase of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","688331","LU1064131003.USD","BK1161","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","09995","LU2328871848.SGD","BK1583","BK0239","LU2488822045.USD"],"gpt_icon":0},{"id":"1188431529","title":"RemeGen (9995) Announces Strong 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1188431529","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188431529?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:28","pubTimestamp":1772191706,"startTime":"0","endTime":"0","summary":"RemeGen (9995) reported a notable increase in operating revenue for 2025, reaching 3.25 billion renminbi, an 89.36% rise from the previous year. The company’s net profit attributable to owners of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"1197540587","title":"RemeGen (09995.HK) Reports January 2026 Share Capital Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1197540587","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197540587?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:43","pubTimestamp":1772008999,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"1122802079","title":"RemeGen (09995.HK / 688331.SH) Announces January 2026 Monthly Securities Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1122802079","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122802079?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:53","pubTimestamp":1770281630,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. disclosed its monthly return for January 2026, detailing the status of its H shares and A shares. According to the announcement, the total authorized share capital at the end of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"2608831826","title":"RemeGen to Swing to Profit in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2608831826","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608831826?lang=en_us&edition=fundamental","pubTime":"2026-02-02 11:55","pubTimestamp":1770004557,"startTime":"0","endTime":"0","summary":"RemeGen  expects 716 million yuan in attributable profit for 2025, which would mark a turnaround from a 1.47 billion yuan loss in 2024, according to a Hong Kong bourse filing Friday.Shares of the biopharmaceutical company fell nearly 4% in late morning trade on Monday.Operating revenue for the year is expected to be 3.25 billion yuan, rising 89% year on year from the 1.72 billion yuan generated in 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1583","LU1969619763.USD","LU2328871848.SGD","BK1161","09995"],"gpt_icon":0},{"id":"1170972893","title":"Hong Kong Stocks Movement | REMEGEN (09995) Rises Nearly 4% Post Profit Alert; Forecasts 2025 Net Profit Attributable to Owners of Approximately RMB 716 Million, Significantly Improved Profitability Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=1170972893","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170972893?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:30","pubTimestamp":1769995827,"startTime":"0","endTime":"0","summary":"Following a positive profit alert, REMEGEN (09995) saw an increase of nearly 4%. As of the time of writing, the stock was up 3.68%, trading at HKD 87.3, with a turnover of HKD 6.0674 million. On...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VT","LU2488822045.USD","688331","BK0239","LU1969619763.USD","LU2328871848.SGD","BK1583","BK1574","BK4585","BK4588","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD","09995"],"gpt_icon":0},{"id":"2607073323","title":"Have Insiders Sold RemeGen Shares Recently?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073323","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607073323?lang=en_us&edition=fundamental","pubTime":"2026-01-31 07:10","pubTimestamp":1769814645,"startTime":"0","endTime":"0","summary":"We wouldn't blame RemeGen Co., Ltd. ( HKG:9995 ) shareholders if they were a little worried about the fact that Jianmin...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/have-insiders-sold-remegen-shares-recently","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/have-insiders-sold-remegen-shares-recently","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","LU1969619763.USD","BK1574","LU2328871848.SGD","BK1161","09995"],"gpt_icon":0},{"id":"2606028261","title":"RemeGen (SEHK:9995) Is Down 7.8% After US$650m AbbVie PD-1/VEGF Licensing Deal News - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606028261","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606028261?lang=en_us&edition=fundamental","pubTime":"2026-01-26 02:18","pubTimestamp":1769365122,"startTime":"0","endTime":"0","summary":"Earlier in January 2026, AbbVie and RemeGen announced an exclusive licensing agreement for RC148, a PD-1/VEGF bispecific antibody for advanced solid tumors, giving AbbVie rights outside Greater China in exchange for an upfront US$650 million payment plus very large potential milestone payments and tiered double-digit royalties.\nThe deal not only validates RemeGen’s oncology platform but also links RC148 to AbbVie’s antibody-drug conjugate pipeline, broadening future combination therapy...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-is-down-78-after-us650m-abbvie-pd-1vegf-lic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-is-down-78-after-us650m-abbvie-pd-1vegf-lic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4559","LU1061106388.HKD","LU1430594728.SGD","LU0545039389.USD","LU2129689431.USD","IE00BLSP4452.SGD","LU1551013342.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU1162221912.USD","LU0511384066.AUD","LU0912757837.SGD","LU1244550494.USD","LU0689472784.USD","SG9999015945.SGD","LU2237443549.SGD","ABBV","SG9999003800.SGD","LU0943347566.SGD","BK1161","LU1929549753.HKD","SG9999015978.USD","LU1585245621.USD","LU0417517546.SGD","LU2089984988.USD","LU0965508806.USD","LU0861579265.USD","LU1244550221.USD","09995","LU1291159041.SGD","LU0211327993.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","IE00BVYPNV92.GBP","LU0122379950.USD","LU1983299246.USD","LU0472753341.HKD","LU2328871848.SGD","SG9999001440.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2087621335.USD","LU1093756325.SGD","BK4139","LU2237443382.USD","PD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU2129689605.HKD"],"gpt_icon":0},{"id":"1109523509","title":"Hong Kong Stock Movement | Rongchang Biotech (09995) Rises Nearly 4% as Institutions See Collaboration with AbbVie Boosting RC148 R&D and Global Commercial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1109523509","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109523509?lang=en_us&edition=fundamental","pubTime":"2026-01-23 10:50","pubTimestamp":1769136624,"startTime":"0","endTime":"0","summary":"Rongchang Biotech (09995) rose nearly 4%, with a gain of 2.96% to HK$92.3 at the time of writing and a turnover of HK$206 million. UBS released a research report expressing a positive view on the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK1574","BK1610","LU1064130708.USD","BK1583","LU1064131003.USD","02800","LU2148510915.USD","BK1161","LU2328871848.SGD","LU2488822045.USD","09995","LU1969619763.USD","BK0239"],"gpt_icon":1},{"id":"2605786125","title":"RemeGen Completes Share Buyback After First Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2605786125","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605786125?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:32","pubTimestamp":1768959129,"startTime":"0","endTime":"0","summary":"RemeGen  has completed its share repurchase plan after buying back 194,144 of its China-listed shares for about 20 million yuan, according to a Wednesday Hong Kong bourse filing.The biopharmaceutical company repurchased the shares on Jan. 20 through centralized bidding at prices ranging from 102.17 yuan to 103.78 yuan per share. The repurchased shares represented about 0.03% of its total issued share capital.The buyback reached the lower end of the approved repurchase amount of 20 million yuan to 40 million yuan, bringing the repurchase plan to completion, the company said.The repurchased shares will be held in a dedicated securities account and are intended for future employee stock ownership plans or equity incentives, the filing showed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1064130708.USD","LU2328871848.SGD","688331","LU2148510915.USD","BK1574","BK1583","BK1161","BK0239","LU1064131003.USD","LU1969619763.USD","LU2488822045.USD","09995"],"gpt_icon":0},{"id":"2603295991","title":"RemeGen Lifts Price Cap on Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2603295991","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603295991?lang=en_us&edition=fundamental","pubTime":"2026-01-16 12:10","pubTimestamp":1768536623,"startTime":"0","endTime":"0","summary":"RemeGen  said it was lifting the price cap on the repurchase of its shares from the open market, according to a Hong Kong bourse filing Thursday.Shares of the biopharmaceutical research company gained nearly 3% in morning trade Friday.The firm will now pay up to 116 yuan per share as opposed to the previous cap of 95 million yuan apiece previously.The company's board approved a share repurchase program in December to buy back between 20 million yuan and 40 million yuan worth of stocks.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1583","09995","LU2328871848.SGD","LU1969619763.USD","BK1161"],"gpt_icon":0},{"id":"1194056253","title":"Stock Track | REMEGEN Soars 5.09% Intraday on AbbVie Licensing Deal for RC148","url":"https://stock-news.laohu8.com/highlight/detail?id=1194056253","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194056253?lang=en_us&edition=fundamental","pubTime":"2026-01-16 09:44","pubTimestamp":1768527886,"startTime":"0","endTime":"0","summary":"REMEGEN's stock surged 5.09% during the intraday session on Friday, driven by investor optimism following the announcement of an exclusive licensing agreement with AbbVie for RC148, a PD-1/VEGF...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"gpt_icon":0},{"id":"1149591971","title":"HK Market Daily: PBOC Cuts Key Rates by 25bps; State Grid Plans 4 Trillion Yuan \"16th Five-Year\" Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1149591971","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149591971?lang=en_us&edition=fundamental","pubTime":"2026-01-16 08:05","pubTimestamp":1768521907,"startTime":"0","endTime":"0","summary":"The People's Bank of China announced that, effective January 19, it will lower the interest rates for relending and rediscount facilities by 0.25 percentage points. This move aims to enhance the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"531ba096f5502f39f4937c4f27f3448f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1116","LU0052750758.USD","BK1190","LU0164880469.USD","LU0708995583.HKD","BK4574","LU1481107354.HKD","BK4581","603993","LU2213484517.USD","BK1161","BK4509","IE0032431581.USD","BK1569","LU1969619763.USD","BK4099","LU1880383366.USD","BK4555","NIO.SI","BK4585","UBmain","603906","BK1110","02190","BK1500","BK4534","ZBmain","ZTmain","LU0072462343.USD","LU0149721374.USD","BK4548","BK4526","EVS.SI","LU0320764599.SGD","BK1601","ZFmain","BK1100","BK4504","NIO","002352","BK1574","09995","TNmain","00001","06936","BK4531","LU2328871848.SGD","02579","688331","BK4532","ZNmain","02465","03993","LU1571399168.USD","BK1583","BK1592","BK1594","BK1521","LU1048588211.SGD","CKHUY","BK1230","LU1880383440.USD","BK4505","BK4588","09866","BK1151","300919"],"gpt_icon":1},{"id":"2603393309","title":"Assessing RemeGen (SEHK:9995) Valuation After AbbVie RC148 Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603393309","media":"Simply Wall St.","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603393309?lang=en_us&edition=fundamental","pubTime":"2026-01-16 01:27","pubTimestamp":1768498034,"startTime":"0","endTime":"0","summary":"Why AbbVie’s RC148 licensing deal matters for RemeGen\nRemeGen (SEHK:9995) moved into focus after AbbVie signed an exclusive licensing agreement for RC148, a PD-1/VEGF bispecific antibody. The deal grants AbbVie rights outside Greater China and secures sizeable upfront, milestone and royalty economics for RemeGen.\nSee our latest analysis for RemeGen.\nRemeGen’s share price has responded sharply to the AbbVie announcement, with a 23.53% 1 month share price return and a very large 1 year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/assessing-remegen-sehk9995-valuation-after-abbvie-rc148-lice","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/assessing-remegen-sehk9995-valuation-after-abbvie-rc148-lice","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0417517546.SGD","LU0661504455.SGD","LU0738911758.USD","09995","LU1061106388.HKD","BK4581","LU2237443465.HKD","IE00BSNM7G36.USD","LU1929549753.HKD","IE00B42XCP33.USD","DCF","LU2237443895.HKD","IE00BJT1NW94.SGD","LU0128525929.USD","LU2129689431.USD","IE00BVYPNW00.USD","LU1023059063.AUD","LU1037948897.HKD","LU2089283258.USD","LU1244550494.USD","LU0882574055.USD","BK4534","LU1839511570.USD","LU0158827948.USD","LU0211328371.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU0432979614.USD","LU0708994859.HKD","LU0965509010.AUD","LU2468319806.SGD","LU0689626769.HKD","IE00B2B36J28.USD","LU1244550577.SGD","IE00BDGV0183.EUR","LU1718418525.SGD","IE0009355771.USD","LU0965509283.SGD","ABBV","LU0820561818.USD","LU0234572021.USD","LU0124676726.USD","LU0256863811.USD","LU0320765646.SGD","LU0689472784.USD","LU2023251221.USD","LU0029864427.USD","LU2237443622.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"1169098864","title":"Huaxi Securities Maintains \"Overweight\" Rating on REMEGEN (09995) as RC148 Bispecific Antibody Goes Global in $5.6 Billion Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1169098864","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169098864?lang=en_us&edition=fundamental","pubTime":"2026-01-15 09:26","pubTimestamp":1768440408,"startTime":"0","endTime":"0","summary":"Huaxi Securities has released a research report maintaining an \"Overweight\" rating on REMEGEN (09995). The brokerage firm highlights the company's robust independent R&D capabilities, steady growth...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU2148510915.USD","LU1064130708.USD","002926","LU2488822045.USD","BK1583","LU1969619763.USD","LU2328871848.SGD","BK1161","688331","BK0239","BK0276","09995","LU1064131003.USD"],"gpt_icon":0},{"id":"1132249843","title":"Zhutong Hong Kong Stock Connect Active Trading | January 13","url":"https://stock-news.laohu8.com/highlight/detail?id=1132249843","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132249843?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:14","pubTimestamp":1768302845,"startTime":"0","endTime":"0","summary":"On January 13, 2026, Alibaba-W (09988), Tencent Holdings (00700), and Xiaomi Group-W (01810) ranked as the top three stocks by turnover value on the Shanghai-Hong Kong Stock Connect (Southbound),...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0329678170.USD","LU1048596156.SGD","LU1196710864.SGD","LU0164865239.USD","LU0531971595.HKD","LU2087589342.USD","BK1506","SG9999014880.SGD","LU1226287529.USD","LU1251922891.USD","LU0608807433.USD","LU0251144936.SGD","IE00B031HY20.USD","BK4534","LU1522347837.USD","LU2097828714.EUR","LU0096374516.USD","LU0648948544.HKD","02228","09995","LU0449509016.USD","SG9999002463.SGD","LU1224709979.USD","LU0264606111.USD","BK1142","LU1807302812.USD","LU0431992006.USD","00700","LU1629966141.USD","LU0630378692.HKD","IE0003795394.USD","LU0823039010.USD","LU0572939691.SGD","LU0106959298.USD","BK1609","LU1366334651.USD","LU0762541174.USD","LU0269904917.USD","LU0898667661.SGD","LU0327786744.USD","SGXZ49509284.SGD","SG9999018857.SGD","LU1105468828.SGD","SG9999000418.SGD","LU0052750758.USD","LU0577902454.USD","LU0819123356.HKD","HK0000320223.HKD","LU0310800965.SGD","LU0594300179.USD","LU0823426480.USD","LU0828237510.HKD","LU1733274390.USD","SG9999013353.USD","02269","LU1497733631.SGD","IE0032834883.USD","LU1769817096.USD","LU1813983027.USD","LU0918141705.HKD","LU0886674414.USD","LU2237443382.USD","LU0211977185.USD","81810","LU0449515922.USD","LU0572944931.SGD","LU0345769128.USD","LU0543330566.HKD","LU1196710195.USD","BK1614","LU2237443465.HKD","SG9999001226.SGD","LU0259732245.USD","BK1546","LU0070217475.USD","LU0572940350.SGD","BK1141","LU2039709279.SGD","BK4220","LU0132412106.USD","BK1588","BK4548","LU0348766576.USD","IE00B031J352.USD","LU0396098781.USD","LU0588546209.SGD","LU0039217434.USD","METmain","LU2051468812.USD","00941","HK0000352382.USD","LU0633140727.USD","LU0865486749.SGD","BK1516","IE0003895053.USD","LU1282649141.HKD","BK1608","LU1868837565.USD","BK1233","LU0072913022.USD","LU0196878994.USD","BK4607","LU0244354667.USD","LU0543330483.HKD","LU0979878070.USD","LU2247934214.USD","IE00B8L5B284.USD","LU2148611432.USD","BK4526","LU1044876610.USD","LU0949170772.SGD","LU1044875133.USD","LU1548497426.USD","81024","LU0229945570.USD","LU1675838814.USD","LU1634259557.SGD","LU0210527791.USD","LU0708995583.HKD","XIACY","LU0192582467.USD","LU0128522744.USD","HBBD.SI","LU0359201885.HKD","BK4554","LU0545039389.USD","LU0348783233.USD","LU0049112450.USD","BK1249","00981","BK4505","LU0029874905.USD","LU1769817179.HKD","BK4614","SGXZ51526630.SGD","LU0708995153.HKD","BK1536","LU0287142896.SGD","LU1634259391.SGD","LU1211504680.USD","LU0164880469.USD","BK1526","BK4503","BK1590","LU0047713382.USD","LU0880133367.SGD","SG9999004220.SGD","SGXZ81163826.USD","SG9999002562.SGD","LU1655091459.SGD","BK1576","LU0823038988.USD","LU0878005551.USD","LU1642822792.SGD","IE0003851619.USD","LU2045819591.USD","LU2097828474.EUR","LU1282649810.SGD","BK1501","BK1161","002202","80883","LU0254981946.USD","SGXZ90724238.SGD","LU0577902611.USD","LU1048484197.HKD","LU0738911758.USD","LU0577902298.EUR","LU0762542818.HKD","LU0650527681.SGD","LU1868837722.USD","LU0516422952.EUR","HK0000165453.HKD","LU0345775950.USD","LU2279701549.SGD","LU0164872284.USD","LU0499858602.USD","LU0499858438.USD","LU2462611646.USD","IE00B8HQ1Z84.USD","600941","BK1584","03690","LU1282648689.USD","LU0784639295.USD","LU0210533765.USD","LU1804176565.USD","BK4587","LU1974910355.USD","LU0762540952.USD","LU0140636845.USD","LU1323998911.USD","HK0000306685.HKD","LU0348723411.USD","LU0823413660.USD","LU1008478684.HKD","LU1152091168.USD","LU1785774172.SGD","BK1618","LU0700851271.USD","LU0289960550.SGD","LU2399975544.HKD","LU0516423091.SGD","HK0000320264.USD","LU1794554557.SGD","LU1810669033.SGD","HXXD.SI","BK4531","IE00BMPRXN33.USD","BK1574","LU0642271901.SGD","LU0972618739.USD","LU1880398554.USD","LU2251237306.USD","LU0828237940.HKD","LU1226288170.HKD","LU0630378429.USD","LU0823413587.USD","IE0008368304.USD","LU1568876335.HKD","LU0588545490.SGD","LU2488822045.USD","LU1242518931.SGD","SG9999001093.SGD","LU0469268626.HKD","LU0882747503.HKD","IE00BMPRXR70.SGD","LU1439102457.SGD","KSTmain","LU0214875030.USD","LU0577902371.SGD","LU0359202008.SGD","BK1586","SG9999018865.SGD","LU0181495838.USD","LU0633140560.USD","LU0648000940.SGD","LU0797268264.HKD","LU1282651048.USD","MIUmain","LU0607220059.USD","TCEHY","LU1956131251.USD","LU0594300419.USD","LU1201861165.SGD","SG9999002828.SGD","LU0553294199.USD","LU0348814723.USD","LU0985320562.USD","LU0348783662.USD","IE00B3M56506.USD","LU2265009873.SGD","LU0873338254.USD","IE0032431581.USD","BK4533","LU0307460666.USD","LU0738912210.USD","LU0117841782.USD","LU0455707207.USD","LU0293314216.USD","LU0384037296.USD","SG9999000459.SGD","LU0918141887.USD","LU0791590937.USD","LU1720050803.USD","LU0823040885.USD","LU1226288097.SGD","LU0540923850.HKD","LU0661504455.SGD","LU1115378108.SGD","LU1961090484.USD","LU2023250504.SGD","LU2357305700.SGD","LU1880383366.USD","IE00B97KM107.HKD","LU1439103000.SGD","BK1502","LU0868486357.SGD","LU0149534421.HKD","LU1688375341.USD","LU0819121731.USD","LU0261950983.USD","BK4575","HK0000352291.HKD","IE0008368742.USD","LU0588545730.USD","SGXZ99366536.SGD","LU0169518387.USD","IE00B0169N27.USD","BK1583","LU1720051108.HKD","LU0203347892.USD","LU0052756011.USD","MPNGY","HK0000914686.HKD","LU0329678337.USD","LU0061477393.USD","LU0163747925.USD","LU0417516571.SGD","BK1193","GB00BDT5M118.USD","LU2097829019.USD","LU0106259558.USD","BK4122","BK4502","BK1095","LU1823568750.SGD","LU0561508036.HKD","LU1064130708.USD","IE00B067MR52.USD","LU2237443622.USD","SGXZ81514606.USD","LU0348805143.USD","SG9999014898.SGD","LU0828238088.HKD","LU2148510915.USD","LU0054450605.USD","IE0009570106.USD","LU0326950275.SGD","IE00BZ08YT58.USD","LU1282649067.USD","LU0675040207.SGD","LU0541501648.USD","LU0531970944.HKD","LU0823397285.USD","LU0370786039.SGD","LU0488056044.USD","LU0348788117.USD","LU1226287792.SGD","SG9999001903.USD","LU1235294995.USD","IE00BFMHRM44.USD","688331","LU0588545904.SGD","LU0683595622.HKD","LU1282651121.HKD","LU0823397103.USD","LU0315179316.USD","LU0320764243.SGD","LU0634319403.HKD","BK1617","LU0640798160.USD","LU0441854154.USD","LU0831103253.SGD","LU2237443978.SGD","LU0128522157.USD","LU1226287875.USD","LU1981816686.USD","BK4527","LU0130518102.USD","LU1226288253.USD","LU1883866441.USD","LU1046422090.SGD","IE0031814852.USD","IE00BF5LJ272.USD","LU0593848301.USD","LU2097828805.USD","LU1242518857.USD","09926","LU0651947912.USD","LU1917777945.USD","LU0871576103.HKD","LU2097828631.EUR","BK1517","LU1023057109.AUD","09988","LU0211331839.USD","LU0477156797.USD","LU0651946864.USD","LU2106854487.HKD","BK1575","LU1831875114.USD","LU0516422366.SGD","LU3063872942.SGD","BK1205","SG9999001069.SGD","LU0823041008.USD","BK4538","LU1725190679.HKD","LU1733274473.HKD","BK1531","LU1102505762.USD","LU1719994722.HKD","LU2008162690.USD","WXXWY","SG9999015952.SGD","IE00BGV7N243.SGD","LU2449936058.SGD","LU0080751232.USD","SG9999003461.SGD","SG9999007991.SGD","LU0823426308.USD","LU2226246903.HKD","IE0008369823.USD","LU0501845795.SGD","00883","LU0345769631.USD","BK1591","SG9999015978.USD","LU0175139822.USD","LU0878004406.USD","HK0000914660.USD","01024","LU1046421795.USD","LU0188438112.USD","LU0326948709.USD","BK4565","BK4535","LU1224444064.USD","LU0456827905.SGD","LU0127658192.USD","SG9999014914.USD","BK4524","LU1960683339.HKD","LU1328277881.USD","LU1051768304.USD","LU0516422440.USD","BABA","LU0210526637.USD","LU2237443549.SGD","LU0345776255.USD","LU0456842615.SGD","LU0143863784.USD","IE00BZ08YR35.GBP","BK4581","LU1328615791.USD","IE00B543WZ88.USD","HMTD.SI","LU0128525689.USD","LU0072462343.USD","LU0235996351.USD","BK1607","LU2133065610.SGD","HK0000252152.HKD","BK1528","LU0359201612.USD","LU1366334578.USD","LU1102505929.USD","LU0502904849.HKD","LU0509642566.USD","LU0348735423.USD","BK4579","LU0608807946.USD","LU1003077747.HKD","LU0197773160.USD","IE00BZ08YS42.EUR","LU0856984785.SGD","LU2097828557.USD","LU1868838027.USD","LU0577902538.SGD","LU1568876251.USD","BK1589","LU0117844026.USD","LU0417516902.SGD","LU0011963245.USD","HTCD.SI","LU0672654166.SGD","LU1880383440.USD","LU0130103400.USD","LU1497734951.SGD","SG9999014906.USD","SG9999015986.USD","LU0067412154.USD","IE00B29SXG58.USD","LU2257852520.SGD","LU0084288322.USD","SG9999006597.SGD","LU2362541273.HKD","SG9999017495.SGD","BK1615","BK0214","SG9999000327.SGD","BK1610","LU1720051017.SGD","LU0203345920.USD","LU0417516738.SGD","IE00BPRC5H50.USD","LU2362541513.USD","LU0831093199.SGD","SGXZ31699556.SGD","LU2125910849.SGD","SG9999001846.SGD","LU2251237488.HKD","LU1303224171.USD","LU1316542783.SGD","LU0029875118.USD","LU0348825331.USD","BK1152","LU1497733557.USD","LU0589944569.HKD","LU1814569148.SGD","LU0165289439.USD","IE0001KFT4U8.USD","BK4504","IE00BQXX3D17.EUR","LU0737861699.HKD","SG9999014674.SGD","LU2476274720.SGD","LU0043850808.USD","LU0890818403.SGD","LU0173614495.USD","LU0348827113.USD","LU1044874839.SGD","LU0516423174.USD","IE00B5MMRT66.SGD","LU0143863198.USD","LU0348767384.USD","BK1513","LU2317271919.USD","LU0791591158.USD","LU0314109678.HKD","LU0821914370.USD","BK4585","LU0320764599.SGD","LU1880398471.USD","HK0000500386.USD","LU0320764755.SGD","HK0000252160.HKD","89988","LU0048580855.USD","LU0541502299.USD","LU0315178854.USD","LU1504937902.USD","IE00BQXX3C00.GBP","SG9999001689.USD","LU0149721374.USD","LU1808992512.USD","LU2498475776.HKD","LU1051769294.HKD","LU1481107354.HKD","LU0051755006.USD","LU1770034418.SGD","LU1188198961.HKD","LU0414403682.SGD","LU0737861772.HKD","LU0048388663.USD","LU1515016050.SGD","LU1969619763.USD","LU1993786604.SGD","688981","BK4543","BK1238","LU0862451837.USD","01810","LU2328871848.SGD","LU0106252389.USD","LU1267930227.SGD","LU1734074674.USD","LU0049853897.USD","LU2177674079.SGD","BK1558","LU0786609619.USD","LU0328353924.USD","HK0000306701.USD","LU0605514214.HKD","BK4588","LU0348784397.USD","LU1951186391.HKD","LU1196710351.USD","BK1523","LU0048597586.USD","LU2293587155.HKD","LU0231483743.USD","LU0228367735.SGD","IE0034224299.USD","LU1235295612.USD","LU1718418525.SGD","IE00BQXX3F31.USD","IE00B0169L03.USD","LU2362540622.SGD","LU2237443895.HKD","LU1064131003.USD","LU2125910500.SGD","BK1604","LU0107464264.USD","LU1048588211.SGD","SG9999001051.SGD","IE00B031HW06.USD","SG9999006514.SGD","LU0228659784.USD","LU2778985437.USD","LU0261947096.USD","LU0197773673.USD","BK1594","LU0611395673.USD","LU1152091754.HKD","LU0251143458.SGD","IE00B0JY6N72.USD","IE0008368411.USD","LU0348816934.USD","LU0054237671.USD","LU0463099449.HKD","LU1770036033.HKD","LU2242644610.SGD","LU2152927971.USD","02208","BK1163","BK4558","BK1521","LU0456846285.SGD","LU0862451753.SGD","LU2476274308.USD","600938"],"gpt_icon":1},{"id":"2603579409","title":"RemeGen Sells License to Anti-tumor Medicine RC148; Shares Jump 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603579409","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603579409?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:31","pubTimestamp":1768275073,"startTime":"0","endTime":"0","summary":"RemeGen (HKG:9995) sold the license to its RC148 medicine to AbbVie, under a deal with an upfront payment of $650 million, according to a Hong Kong bourse filing Monday.Shares of the biopharmaceutical","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09995","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1201},{"period":"1month","weight":0.0845},{"period":"3month","weight":0.1305},{"period":"6month","weight":-0.1583},{"period":"1year","weight":3.7949},{"period":"ytd","weight":0.1854}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":-0.009077},{"month":4,"riseRate":0.8,"avgChangeRate":0.104301},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}